| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,776 | 13,165 | 9,429 | 67,049 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 13,776 | 13,165 | 9,429 | 67,049 | | | Operating Expenses | | Research Development | 18,499 | 20,713 | 21,242 | 16,437 | | Selling General and Administrative | 4,570 | 5,681 | 5,330 | 5,602 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,294) | (13,229) | (17,143) | 45,010 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 401 | 2,337 | 13,192 | 1,764 | | Earnings Before Interest And Taxes | (8,892) | (10,892) | (3,950) | 46,773 | | Interest Expense | 433 | 433 | 0 | 2 | | Income Before Tax | (9,326) | (11,325) | (3,950) | 46,772 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,326) | (11,325) | (3,950) | 46,772 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,326) | (11,325) | (3,950) | 46,772 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,326) | ($11,325) | ($3,950) | $46,772 |
|
0.20% Nasdaq 
Income Statement
